Press Releases

Press Releases

New approach estimates tuberculosis burden in India, models transmission dynamics of urban and rural regions

 

Improved estimates of tuberculosis incidence are urgently needed to support effective control programs

NEW DELHI –India bears the highest burden of tuberculosis (TB) globally, about 25 percent of all cases. The extent of TB in high-burden and low-resource regions is difficult to measure directly, but knowing the number of cases is necessary to plan, staff and finance control programs.

Diphtheria-Pertussis-Tetanus vaccine participation among Indian children, study identifies major influences

January 17, 2017

Parents’ education and healthcare access affect diphtheria-pertussis-tetanus (DPT) vaccine uptake among children in India

Complete vaccination with the three-dose series of the diphtheria-pertussis-tetanus (DPT) vaccine is a widely used indicator of national routine immunization performance. In 2014, Indian children accounted for 22 percent of the 18.7 million children worldwide who had not completed three doses by age one.

First large-scale study to examine factors associated with recurrent emergency department visits for skin and soft tissue infections

December 20, 2016

More than 16 percent of all emergency department visits for skin and soft tissue infections (SSTIs) were for a recurrent infection

A study from CDDEP researchers and collaborators finds an association between recurrent emergency department (ED) visits for skin and soft tissue infections (SSTI), sociodemographic factors and comorbidities, using California emergency department discharge data from 2005 to 2011.

Antimicrobial-resistant healthcare-associated infection increased dramatically among U.S. children

November 17, 2016

In just over a decade, multidrug-resistant cases of Pseudomonas aeruginosa have increased from 15 percent to 26 percent of all P. aeruginosa cases

In a study published today in The Journal of the Pediatric Infectious Diseases Society, CDDEP researchers and collaborators have found that infections due to multidrug-resistant and carbapenem-resistant strains of Pseudomonas aeruginosa increased dramatically between 1999 and 2012.

Resource-poor countries experience higher levels of antimicrobial resistance

October 12, 2016

Study reveals strong association between country income status and antimicrobial resistance prevalence

The first study to examine the association between national income and antimicrobial resistance (AMR) prevalence, conducted by CDDEP researchers and collaborators, found that AMR prevalence increases as national income decreases.  AMR levels are highest in the poorest countries, underscoring the urgent necessity of new policies to address AMR in resource-poor settings.

Experts call for global antimicrobial conservation fund to stem overuse of antibiotics

September 28, 2016

The fund would support antimicrobial stewardship efforts in low- and middle- income countries

CDDEP Director Ramanan Laxminarayan and other experts in antimicrobial resistance (AMR) make the case for a Global Antimicrobial Conservation Fund, in an International Journal of Infectious Diseases editorial. The fund would support antimicrobial stewardship programs in low- and middle-income countries (LMICs), which include the BRICS nations (Brazil, Russia, India, China and South Africa), currently driving consumption in both animal and human sectors.

Antimicrobial resistance in India threatens the survival of newborns

September 21, 2016

Multicenter study of neonatal sepsis and resistance in India underscores the need for greater attention and prevention strategies

In a large multi-center study of neonatal sepsis in tertiary care hospitals in India, sepsis incidence and mortality was high and antimicrobial resistance increased the case fatality rates. Overall, nearly one-quarter of the neonatal deaths were from sepsis. The results, published in The Lancet, indicate the need to understand the pathogenesis of sepsis in newborns and infants, as well as the need to implement proven infection control interventions to prevent the illness in low-income and middle-income countries.

Alliance to support UN resolution against antimicrobial resistance formed by leading global health organizations

September 20, 2016

The Conscience of Antimicrobial Resistance Accountability (CARA) is an alliance to support the United Nations Resolution on Antimicrobial Resistance

WASHINGTON, D.C. - Nine founding organizations have launched CARA—the Conscience of Antimicrobial Resistance Accountability—an alliance formed in anticipation of the Resolution to be introduced at the UN General Assembly High-Level Meeting on Antimicrobial Resistance. More organizations from the public and private sectors around the world are expected to join in the coming months.

$1.72 trillion in economic productivity has resulted from polio eradication efforts in India, nearly 400,000 deaths prevented

September 19, 2016

Three decades of polio eradication efforts in India has saved more than 390,000 lives, averted nearly 4 million cases of paralysis and boosted productivity by US$1.71 trillion

CDDEP-contributed research published in Indian Pediatrics has examined the health and economic benefits of three decades of polio eradication efforts in India, estimating that India has averted 3.94 million paralytic cases of polio, 393,918 related deaths, and 1.48 billion disability-adjusted life-years (DALYs). As a result of eradication efforts, India has also gained US$1.71 trillion in economic productivity between 1982 and 2012, according to the study’s base case analysis.

Fuel blockade in Nepal has earthquake-level health effects

September 19, 2016

After a devastating earthquake in April 2015, Nepal is set back by another disaster, a fuel blockade imposed by India for political leverage

A blockade imposed by India in fall 2015, in response to provisions of Nepal’s new constitution, led to a severe fuel crisis, which has caused devastating health consequences for the population of Nepal. BP Koirala Institute of Health Science Assistant Professor Shyam Sundar Budhathoki and CDDEP Associate Director for Policy Hellen Gelband comment on the blockade in BMJ Global Health.

Pages

Contact

The Center for Disease Dynamics, Economics & Policy
1400 Eye ST NW, Suite 500
Washington, DC 20005
+1-202-328-5152 voice
+1-202-328-5170 fax

For media inquiries, e-mail communications@cddep.org. For general inquiries, send us a message with the form below.